Hungarian National Institute of Pharmacy and Nutrition (OGYEI) has granted a Good Manufacturing Practice (GMP) certificate to CanSino Biologics, a Chinese vaccine manufacturer founded in 2009, for its COVID-19 vaccine known as Convidecia.
According to details, OGYEI issued the GMP certificate to CanSinoBIO on 21 May after a comprehensive inspection of CanSinoBIO’s manufacturing of Convidecia.
ALSO READ
KP Chief Minister Goes Undercover and Catches Officials Taking Bribes [Video]
The GMP certificate by an EU member shows that CanSinoBIO’s manufacturing facilities and quality control system are in line with high production standards and guidelines laid down by the EU.
The EU’s GMP certificate is required to import COVID-19 vaccines into Europe which indicates that CanSinoBIO is ready to enter more markets in Europe and globally.
In an official statement, Dr. Xuefeng YU, Chairman and CEO of CanSinoBIO, said:
We are pleased to receive the GMP certificate by the European Union, which is a testament to our capability to safely and reliably produce COVID-19 vaccines when many countries around the world are still in desperate need of mass protection from this pandemic.
ALSO READ
Shahbaz Gill Makes a Big Announcement on Salaries of Govt Employees
The statement added:
We will continue to support the supply of COVID-19 vaccines to China and other markets and contribute to the global fight against the pandemic by protecting more people’s lives.
Also known as Ad5-nCoV, the CanSinoBIO’s COVID-19 vaccine has already received regulatory approvals in China, Mexico, Pakistan, Hungary, and Chile.
